After 30 years of research, there are now two malaria vaccines.
One, R21/Matrix-M, was approved for use in Ghana and Nigeria in April this year. It was developed by Oxford University scientists and manufactured by the Serum Institute of India and follows the first publicly available malaria jab – RTS,S – which was endorsed by the World Health Organization (WHO) in 2021.
